Skip to main content
. 2020 May 5;10:7516. doi: 10.1038/s41598-020-64485-4

Table 1.

Absolute quantification of tRF levels in plasma samples from epilepsy patients.

5′AlaTGC Patient Molarity 5′GluCTC Patient Molarity 5′GlyGCC Patient Molarity
Pre-seizure E1 0.44aM Pre-seizure E1 0.01 zM Pre-seizure E1 0.13 zM
E2 2.65 aM E2 0.9 zM E2 0.17 zM
E3 324.02 pM E3 0.06 zM E3 19.81 pM
E4 0.06 aM E4 0.01 zM E4 0.23 zM
E5 3.67 aM E5 0.01 zM E5 13.07 pM
E6 0.41 aM E6 11.75 fM E6 36.66 pM
Post-seizure E1 0.05 aM Post-seizure E1 0.01 zM Post-seizure E1 0.80 zM
E2 9.22 zM E2 0.01 zM E2 1.08 zM
E3 328.27 aM E3 0.01 zM E3 2.49 fM
E4 0.02 aM E4 0.01 zM E4 0.34 aM
E5 86.85 aM E5 27.82 aM E5 2.83 zM
E6 0.99 aM E6 0.01 zM E6 1.03 zM

Changes in current were used to calculate absolute levels of tRFs using the curves shown in Fig. 3. The majority of pre-seizure samples showed levels above the LOD however some post seizure samples were below the estimated LODs.